Aframomum melegueta, commonly known as grains of paradise, is a West African botanical traditionally used as both a spice and a medicinal herb. Its seeds contain various bioactive compounds, including gingerol-related compounds, flavonoids, diarylheptanoids, volatile oils, and alkaloids. Recent research has explored its potential benefits for mood, stress, sleep, energy metabolism, inflammation, and pain management. A 2025 randomized, double-blind pilot clinical trial found that Aframomum melegueta seed extract may help relieve anxiety and stress, improve mood, and support sleep quality, with effects showing a dose-dependent pattern. Experimental studies have also investigated its potential effects on FAAH, the endocannabinoid system, serotonin receptors, TRPV1 channels, and brown adipose tissue. These findings highlight the growing interest in grains of paradise as a multifunctional botanical ingredient, although further clinical research is needed to confirm its efficacy and safety in humans.
Aframomum melegueta, commonly known as grains of paradise, is a perennial herbaceous plant belonging to the ginger family (Zingiberaceae). Across West Africa, it has long been integrated into everyday life. On the one hand, it is used as a distinctive spice in traditional cuisine; on the other hand, it is also a classic botanical used in traditional medicine for the management of various discomforts.
Its seeds contain a variety of flavor compounds and bioactive constituents. The pungent vanilloid compounds account for approximately 1.5%–3% and mainly include 6-gingerol, 6-shogaol, and 6-paradol. The seeds also contain flavonoids, diarylheptanoids, volatile oils, alkaloids, and other components.
In 2025, Pharmaceuticals published a randomized, double-blind pilot clinical trial. The study found that Aframomum melegueta seed extract could effectively relieve anxiety, reduce stress, improve mood, and support sleep, while demonstrating good safety, with no obvious adverse reactions observed.
Source: Reference [2]
The trial divided participants into different dosage groups, with participants consuming 50 mg, 100 mg, or 150 mg of Aframomum melegueta extract daily for three consecutive days. Psychological assessment questionnaires were administered before the formal intervention and again 48 hours after the first intake of the extract.
1) Significant Relief of Anxiety and Depressive Mood
The trial results showed that after 48 hours of intervention, participants experienced effective improvements in tension and anxiety, depressed mood, and overall emotional disturbance. Their levels of energy and vitality also increased.
The observations further indicated that the mood-improving effects were dose-dependent, with the regulatory effects becoming more pronounced as the dosage increased. Among the groups, participants who consumed 150 mg of Aframomum melegueta extract daily achieved the best results, with overall emotional disturbance substantially reduced by 77.58%. Looking at individual emotional dimensions, depressive mood improved by 34.76%, while tension and anxiety improved by 19.82%, with significant improvements observed across the measured indicators.
Source: Reference [2]
2) Improved Sleep Quality
At the same time, the study also observed that Aframomum melegueta extract could significantly improve sleep quality, and this effect was likewise dose-dependent. After taking 150 mg of Aframomum melegueta extract for three consecutive days, participants experienced a 51.18% reduction in difficulty falling asleep, a 36.5% improvement in sleep quality, and a 7.4% increase in morning alertness.
Source: Reference [2]
How Does Aframomum melegueta Help Relieve Emotional Stress?
The clinical trial data provide a direct indication that Aframomum melegueta seed extract may help relieve stress and regulate mood within just 48 hours, with the effects becoming more pronounced as the dosage increases. This naturally raises the question: how does it act on the human body to help rapidly ease anxiety and stabilize mood?
The answer may lie in the body's own endocannabinoid system.
Potential mechanism of action of Aframomum melegueta seed extract
Source: Reference [2]
1) Inhibiting FAAH and Increasing Endocannabinoid Levels
In vitro experiments showed that Aframomum melegueta extract can inhibit fatty acid amide hydrolase (FAAH), with an inhibition rate of 92%. FAAH is a key enzyme responsible for degrading the endocannabinoid anandamide (AEA). Inhibiting its activity can increase AEA levels. AEA is known as a "regulator of emotional homeostasis" and plays an important role in relieving anxiety and improving mood. FAAH has now become an important target in the field of anxiety management.
2) Modulating Cannabinoid and Serotonin Receptors
In vitro receptor-binding experiments showed that Aframomum melegueta extract had inhibition rates of 85.5% and 62.3% for the CB2 receptor and 5-HT1A receptor, respectively. The CB2 receptor is mainly distributed in microglial cells and immune cells within the central nervous system. Its activation can inhibit the release of pro-inflammatory factors and produce neuroprotective effects. The 5-HT1A receptor is widely involved in the regulation of mood, anxiety, and sleep.
3) Activating TRPV1 Channels to Produce Analgesic and Anti-Inflammatory Effects
Functional activity experiments confirmed that Aframomum melegueta extract can activate TRPV1 ion channels in a dose-dependent manner. Moderate activation of TRPV1 may produce analgesic effects, reduce inflammatory responses, and indirectly relieve physical discomfort associated with stress.
A Botanical Ingredient with Diverse Health Potential
Aframomum melegueta contains a rich variety of bioactive compounds, giving it diverse potential applications in the health field.
1) Regulation of Energy Metabolism
Brown adipose tissue (BAT) is responsible for cold-induced and diet-induced thermogenesis and plays an important role in whole-body energy expenditure and body fat regulation. A human study showed that after consuming 40 mg of Aframomum melegueta extract, whole-body energy expenditure in the BAT-positive group (individuals with active brown adipose tissue) increased significantly within two hours, while no such response was observed in the BAT-negative group. This indicates that intake of Aframomum melegueta extract increased whole-body energy expenditure by activating BAT.
In addition, 6-paradol, a key active compound in Aframomum melegueta, can significantly downregulate the expression of genes associated with fatty acid synthesis, lipid transport, and adipocyte differentiation, thereby inhibiting weight gain while reducing the accumulation of visceral and subcutaneous fat.
2) Anti-Inflammatory Effects
Inflammation is a common pathological basis of numerous chronic diseases. Related studies have shown that 6-paradol in Aframomum melegueta extract can effectively inhibit COX-2, while 6-shogaol demonstrates a strong ability to downregulate the expression of pro-inflammatory genes. Its anti-inflammatory effects can even reach those of the positive control drug aspirin.
3) Analgesic Effects
Aframomum melegueta also demonstrates certain potential for renal protection. Research has found that 6-gingerol, 6-paradol, and 6-shogaol in Aframomum melegueta can be metabolized by microorganisms to generate a variety of derivatives. These metabolites can bind to AMP-activated protein kinase (AMPK), thereby exerting potential renal-protective effects.
The diverse health potential of Aframomum melegueta is gradually being revealed by modern science. In the future, as more systematic clinical studies are conducted, this traditional West African botanical may have increasingly important applications in functional foods and adjunctive therapeutic fields.
References
[1] NutraIngredients. “Announcing the NutraIngredients Europe Awards 2026 Finalists.” NutraIngredients article
[2] Pérez-Machín, R.; Vega-Morales, T.; Elvira-Aranda, C.; Lledó-Rico, L.; Gomis-Gomis, M.J.; López-Ríos, L. Aframomum melegueta Seed Extract’s Effects on Anxiety, Stress, Mood, and Sleep: A Randomized, Double-Blind, Pilot Clinical Trial. Pharmaceuticals 2025, 18, 278.
[3] Sugita, J., Yoneshiro, T., Hatano, T., Aita, S., Ikemoto, T., Uchiwa, H., Iwanaga, T., Kameya, T., Kawai, Y., & Saito, M. (2013). Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. British Journal of Nutrition, 110(4), 733–738.
[4] Hattori H, Mori T, Shibata T, Kita M, Mitsunaga T. 6-Paradol acts as a potential anti-obesity vanilloid from grains of paradise. Molecular Nutrition & Food Research. 2021;65(17):e202100185.